Daniel H. Zimmerman,Roy Carambula,Harold Steiner,Eyal Talor,Tibor Glant,Katalin Mikecz
申请号：
US14907520
公开号：
US20160158330A1
申请日:
2014.04.28
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention is related to peptide constructs, i.e., polypeptides obtained by linking together two or more peptides based on or derived from different molecules, which are useful in the treatment or prevention of autoimmune diseases, specifically rheumatoid arthritis (RA) and compositions containing same, methods for producing same and methods for using same wherein the peptide constructs have the formulaP1-x-P2whereP1 is a peptide associated with autoimmune disease such as rheumatoid arthritis myocarditis, diabetes, and immune-mediated disease, which binds to an antigen receptor on a set or subset of T cellsP2 is a peptide which will cause a Th2 directed immune response by the set or subset of T cells to which the peptide P1 is attached or which will bind to a T cell receptor which will cause the set or subset of T cells to which the peptide P1 is attached to initiate, but not complete, an immune response causing the set or subset of T cells to undergo immunomodulation including but not restricted to anergy and apoptosis andx is a direct bond or linker for covalently bonding P1 and P2.Whereas said treatment being of the individual itself or of ex vivo treatment of isolated DC and or with further labeling with drug, dye or radioisotope and administration back into the patient of the activated and possibly modified DCs for detection, identification, localization and treatment thereof.
